An animal study examined the effect of Il-12 administration with MRgFUS causing BBBD; the results showed that an increased ratio of lymphocytes T CD8 to CD4 in the tumor region caused retarded tumor progression and an improvement in the average survival rate [180]. The gene discussed is CD8A; the disease is neoplasm.